177 research outputs found
Recommended from our members
Influence of boron doping on the dynamics of formation of Os metal nanoclusters on graphitic surfaces
YesThe fabrication of osmium nanoclusters from single atoms has been studied in real-time on B-doped and B-free graphitic surfaces. The dynamics of nucleation on both surfaces are identified, captured, and reported. The nucleation is ca. 2× faster on B-doped surface compared to the B-free surface (38 pm min−1versus 18 pm min−1), suggesting osmium–boron interactions within the nanomaterials
The synthesis and unexpected solution chemistry of thermochromic carborane-containing osmium half-sandwich complexes
YesThe functionalisation of the 16-electron complex [Os(η6-p-cymene)(1,2-dicarba-closo-dodecarborane-
1,2-dithiolato)] (1) with a series of Lewis bases to give the 18-electron complexes of general formula
[Os(η6-p-cymene)(1,2-dicarba-closo-dodecarborane-1,2-dithiolato)(L)] (L = pyridine (2), 4-dimethylaminopyridine
(3), 4-cyanopyridine (4), 4-methoxypyridine (5), pyrazine (6), pyridazine (7), 4,4’-bipyridine
(8) and triphenylphosphine (9)) is reported. All 18-electron complexes are in equilibrium in solution with
the 16-electron precursor, and thermochromic properties are observed in some cases (2, 3, 5, 8, and 9).
The binding constants and Gibbs free energies of the equilibria are determined using UV-visible titrations
and their stabilities investigated. Synthetic routes for forcing the formation of the 18-electron species are
proposed, and analytical methods to characterise the equilibria are described.We thank the Leverhulme Trust (Early Career Fellowship No. ECF-2013-414 to NPEB), and the University of Warwick (Grant No. RD14102 to NPEB)
Recommended from our members
Polymers and boron neutron capture therapy(BNCT): a potent combination
YesBoron neutron capture therapy (BNCT) has a long history of unfulfilled promises for the treatment of aggressive cancers. In the last two decades, chemists, physicists, and clinical scientists have been coordinating their efforts to overcome practical and scientific challenges needed to unlock its full therapeutic potential. From a chemistry point of view, the two current small-molecule drugs used in the clinic were developed in the 1950s, however, they both lack some of the essential requirements for making BNCT a successful therapeutic modality. Novel strategies are currently used to design new drugs, more selective towards cancer cells and tumours, as well as able to deliver high boron contents to the target. In this context, macromolecules, including polymers, are promising tools to make BNCT an effective, accepted, and front-line therapy against cancer. In this review, we will provide a brief overview of BNCT, and its potential and challenges, and we will discuss the most promising strategies that have been developed so far
Anti-inflammatory activity of electron-deficient organometallics
YesWe report an evaluation of the cytotoxicity of a series of
electron-deficient (16-electron) half-sandwich precious metal
complexes of ruthenium, osmium and iridium ([Os/Ru(η6-pcymene)(
1,2-dicarba-closo-dodecarborane-1,2-dithiolato)] (1/2),
[Ir(η5-pentamethylcyclopentadiene)(1,2-dicarba-closo-dodecarborane-
1,2-dithiolato)] (3), [Os/Ru(η6-p-cymene)(benzene-1,
2-dithiolato)] (4/5) and [Ir(η5-pentamethylcyclopentadiene)
(benzene-1,2-dithiolato)] (6)) towards RAW 264.7 murine
macrophages and MRC-5 fibroblast cells. Complexes 3 and
6 were found to be non-cytotoxic. The anti-inflammatory
activity of 1–6 was evaluated in both cell lines after nitric
oxide (NO) production and inflammation response induced by
bacterial endotoxin lipopolysaccharide (LPS) as the stimulus.
All metal complexes were shown to exhibit dose-dependent
inhibitory effects on LPS-induced NO production on both cell
lines. Remarkably, the two iridium complexes 3 and 6 trigger
a full anti-inflammatory response against LPS-induced NO
production, which opens up new avenues for the development
of non-cytotoxic anti-inflammatory drug candidates with
distinct structures and solution chemistry from that of organic
drugs, and as such with potential novel mechanisms of action.We thank the Royal Society (University Research Fellowship No. UF150295 to NPEB), and the University of Bradford for financial support
Effect of temperature on the nucleation and growth of precious metal nanocrystals
YesUnderstanding the effect of physical parameters (e.g., temperature) on crystallisation dynamics is of paramount importance for the synthesis of nanocrystals of well‐defined sizes and geometries. However, imaging nucleation and growth is an experimental challenge owing to the resolution required and the kinetics involved. Here, by using an aberration‐corrected transmission electron microscope, we report the fabrication of precious metal nanocrystals from nuclei and the identification of the dynamics of their nucleation at three different temperatures (20, 50, and 100 °C). A fast, and apparently linear, acceleration of the growth rate is observed against increasing temperature (78.8, 117.7, and 176.5 pm min−1, respectively). This work appears to be the first direct observation of the effect of temperature on the nucleation and growth of metal nanocrystals.The Royal Society. Grant Number: UF150295 Leverhulme Trust. Grant Number: ECF-2013-414 The Academy of Medical Sciences. Grant Number: SBF003\117
Controlled Release of Carbon Monoxide from a Pseudo Electron- Deficient Organometallic Complex
YesA 16-electron iridium organometallic is reacted with carbon monoxide to form an 18-electron CO-adduct. This
CO-adduct is stable for weeks in the solid state, but quickly reverts to its parent 16-e complex in tetrahydrofuran solution,
releasing CO(g). Using a simple methodology, we show that this gas can subsequently be used to perform a carbonylation
reaction on another molecule.Royal Society; Academy of Medical Sciences/the Wellcome Trust/the Government Department of Business, Energy and Industrial Strategy/the British Heart Foundation Springboard Awar
Enhancement of Cytotoxicity by Combining Pyrenyl-Dendrimers and Arene Ruthenium Metallacages
Three generations of pyrenyl bis-MPA dendrimers with two different end-groups, acetonide (pyrGn) or alcohol (pyrGn-OH) (n = 1–3), were synthesized, and the pyrenyl group of the dendritic molecules was encapsulated in the arene ruthenium metallacages, [Ru6(p-cymene) 6 (OO∩OO)3(tpt)2]6+ (OO∩OO = 5,8-dioxydo- 1,4-naphtaquinonato (donq) [1]6+ and 6,11-dioxydo-5,12- naphtacenedionato (dotq) [2]6+; tpt =2,4,6-tri(pyridin-4-yl)-1,3,5-triazine). The host–guest properties of [guestC1]6+ and [guestC2]6+ were studied in solution by NMR and UV–vis spectroscopic methods, thus allowing the determination of the affinity constants. Moreover, the cytotoxicity of these water- soluble host–guest systems and the pyrenyl-dendrimers was evaluated on human ovarian cancer cells
Arene ruthenium dithiolato-carborane complexes for boron neutron capture theory (BNCT)
YesWe report the effect of low-energy thermal neutron irradiation on the antiproliferative activities of a
highly hydrophobic organometallic arene ruthenium dithiolatoecarborane complex [Ru(p-cymene) (1,2-
dicarba-closo-dodecarborane-1,2-dithiolato)] (1), and of its formulation in Pluronic® triblock copolymer
P123 coreeshell micelles (RuMs). Complex 1 was highly active, with and without neutron irradiation,
towards human ovarian cancer cells (A2780; IC50 0.14 mM and 0.17 mM, respectively) and cisplatinresistant
human ovarian cancer cells (A2780cisR; IC50 0.05 and 0.13 mM, respectively). Complex 1 was
particularly sensitive to neutron irradiation in A2780cisR cells (2.6 more potent after irradiation
compared to non-irradiation). Although less potent, the encapsulated complex 1 as RuMs nanoparticles
resulted in higher cellular accumulation (2.5 ), and was sensitive to neutron irradiation in A2780 cells
(1.4 more potent upon irradiation compared to non-irradiation).We thank the Leverhulme Trust (Early Career Fellowship No. ECF-2013-414 to NPEB), the University of Warwick (Grant No. RD14102 to NPEB), the University of Birmingham/EPSRC Follow-on- Fund (Grant No UOBFOF026 to BP), the ERC (Grant No. 247450 to PJS), EPSRC (EP/F034210/1 to PJS)
- …